LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q 2025 – – Topline 56-week data for LUGANO expected in mid-2026 with ...

Steven T. Reed, O.D., discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults ...

NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

A new study shows that tiny gold particles could circumvent damaged photoreceptors in patients with macular degeneration and help restore vision.

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina.

The aim of anti-VEGF treatment is to dry the retina to eliminate the exudate from ... anti-VEGF agents in patients with nAMD or diabetic macular edema requires frequent monitoring and intravitreal ...

NIH Scientists Test in an Animal Model a Surgical Technique to Improve Cell Therapy for Dry Age-Related Macular Degeneration ...

Age-related macular degeneration (AMD) is a progressive eye disease where the macula – the part of the retina responsible for central vision – ...

Symptoms suggestive of post-injection endophthalmitis or retinal detachment require ... physicians about best practices in the treatment of age-related macular degeneration (AMD).

Researcher works with universities of California-Davis, Illinois, Wisconsin and others to engineer and test a novel microsphere-hydrogel delivery for medicine, requiring fewer injections, to treat a c ...